Fenbendazole encapsulation method

FIELD: chemistry.

SUBSTANCE: invention provides a method of encapsulating a medicinal preparation via nonsolvent deposition, characterised by that the medicinal preparation used is fenbendazole, the envelope used is sodium carboxymethyl cellulose which is deposited from a solution in tetrachloromethane by adding, as the nonsolvent, isopropanol and water at 25°C.

EFFECT: simple and faster process of producing microcapsules, reduced losses when producing microcapsules, high mass output.

3 ex

 

The invention relates to the field of encapsulation, and in particular the production of microcapsules of fenbendazol.

Previously known methods for producing microcapsules of drugs. Thus, in U.S. Pat. RF 2092155, IPC A61K 047/02, A61K 009/16 publ. 10.10.1997, the method of microencapsulation of drugs, based on the use of irradiation with ultraviolet rays.

The disadvantages of this method are the duration of the process and the use of ultraviolet radiation, which can influence the formation of microcapsules.

In Pat. RF 2091071, IPC A61K 35/10 publ. 27.09.1997, the method for obtaining the drug by dispersion in a ball mill to obtain microcapsules.

The disadvantage of this method is the use of a ball mill and the duration of the process.

In Pat. RF 2101010, IPC A61K 9/52, A61K 9/50, A61K 9/22, A61K 9/20, A61K 31/19 publ. 10.01.1998, proposed chewable form of the drug with taste masking, having the properties of a controlled release drug product that contains microcapsules with a size of 100-800 microns in diameter and consists of pharmaceutical kernel crystalline ibuprofen and polymeric coating comprising a plasticizer, elastic enough to resist chewing. The polymer coating is a copolymer based on methacrylic acid is.

The drawbacks of the invention: use of a copolymer based on methacrylic acid, as these polymer coatings can cause cancer; complexity; the duration of the process.

In Pat. RF 2173140, IPC A61K 009/50, A61K 009/127 publ. 10.09.2001, method for obtaining kremnijorganicheskih microcapsules using a rotary cavitation plants with high shear effort and powerful acoustic phenomena of sound and ultrasound range for dispersion.

The disadvantage of this method is the use of special equipment - rotary-cavity setup, which has the ultrasonic action that affects the formation of microcapsules and can cause adverse reactions due to the fact that ultrasound destructive effect on the polymers of protein nature, therefore the proposed method is applicable when working with polymers of synthetic origin.

In Pat. RF 2359662, IPC A61K 009/56, A61J 003/07, B01J 013/02, A23L 001/00 publ. 27.06.2009, proposed a method of producing microcapsules using spray cooling in the spray tower Niro under the following conditions: air temperature at the inlet 10°C, the temperature at the outlet 28°C, the speed of rotation of the spray drum 10000 rpm/min Microcapsules according to the invention have the str is Chennai stability and provide adjustable and/or prolonged release of the active ingredient.

Disadvantages of the proposed method are the duration of the process and the use of special equipment, a set of conditions (temperature of inlet air 10°C, the temperature at the outlet 28°C, the speed of rotation of the spray drum 10000 rpm).

The closest method is the method proposed in U.S. Pat. RF 2134967, IPC A01N 53/00, A01N 25/28 publ. 27.08.1999, is dispersed In water solution mixture of natural lipids and a PYRETHROID insecticide in the weight ratio of 2-4:1 in an organic solvent, which leads to simplification of the method of microencapsulation.

The disadvantage of this method is the dispersion in the aquatic environment, which makes the proposed method applicable to the production of microcapsules of water-soluble drugs in water-soluble polymers.

The technical objective is the simplification and acceleration of the process of production of microcapsules, the reduction of losses upon receipt of the microcapsules (increase in mass).

The solution of the technical problem is achieved by the method of encapsulation of fenbendazol, characterized in that as the shell of the microcapsules used sodium carboxymethylcellulose when receiving physical-chemical method for the deposition nerastvorim using two precipitators - isopropanol and carbon tetrachloride, the retrieval process is carried out without special equipment the Oia.

A distinctive feature of the proposed method is the use of sodium carboxymethylcellulose as the shell of the microcapsules, fenbendazol as their cores, and the use of two precipitators - isopropanol and carbon tetrachloride.

The result of the proposed method are obtaining microcapsules of fenbendazol in the sodium carboxymethyl cellulose at 25°C for 20 minutes. The output of the microcapsules is over 90%.

EXAMPLE 1 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dioxane, the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml of dioxane and the resulting mixture was dispersed in a solution of sodium carboxymethylcellulose in carbon tetrachloride containing the specified 300 mg of the polymer in the presence of 0.01 g of the drug E472c under stirring about 1000/sec. Then poured 2 ml isopropanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0,396 g white to yellowish powder. The yield was 99%.

EXAMPLE 2 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dimethyl sulfoxide (DMSO), the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml DMSO and the mixture was dispersed in a solution of sodium carboxymethylcellulose in carbon tetrachloride containing in asanoha 300 mg of the polymer in the presence of 0.01 g of the drug E472c under stirring about 1000/sec. Then poured 2 ml isopropanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0,396 g white to yellowish powder. The yield was 99%.

EXAMPLE 3 Obtaining microcapsules of fenbendazol with the dissolution of the drug in dimethylformamide (DMF), the ratio of the core/polymer 1:3

100 mg of fenbendazol dissolved in 1 ml DMF and the resulting mixture was dispersed in a solution of sodium carboxymethylcellulose in carbon tetrachloride containing the specified 300 mg of the polymer in the presence of 0.01 g of the drug E472c under stirring about 1000/sec. Then poured 2 ml isopropanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0,396 g white to yellowish powder. The yield was 99%.

The obtained microcapsules of fenbendazol physico-chemical method for the deposition nerastvorim using two precipitators - isopropanol and carbon tetrachloride, which increases output and accelerates the process of microencapsulation. The process is simple to perform and lasts for 20 minutes, requires no special equipment.

The proposed method is suitable for the veterinary industry due to the minimal loss of speed, ease of acquisition and allocation of microcapsules.

The method and the crypto medicinal product by precipitation with aristotelem, characterized in that the medicinal product is used fenbendazol, as the shell - sodium carboxymethylcellulose, which precipitated from solution in carbon tetrachloride by adding as herstories isopropanol and water at 25°C.



 

Same patents:

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to the chemical-pharmaceutical industry, and represents a method for preparing drug microcapsules by non-solvent addition differing by the fact that the drug preparations are presented by cephalosporin preparations, while a coating is a konjak gum that is precipitated in acetone by addition of non-solvents that are carbinol and water at 25°C.

EFFECT: invention provides simplified and accelerated preparation of the water-soluble drug microcapsules of cephalosporins in the konjac gum, loss reduction in preparing the microcapsules (higher yield-mass).

6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the field of pharmaceutics, in particular to microcapsulation of medications of a cephalosporin group, belonging to β-lactam antibiotics, in human serum albumin.

EFFECT: realisation of invention results in simplification and acceleration of the process of obtaining microcapsules of water-soluble medications of the cephalosporin group in human serum albumin, reduction of loss in the process of obtaining microcapsules (increase of the output by weight).

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the field of pharmaceutics, in particular, to obtaining fenbendazole capsules. In realisation of a method simplification and acceleration of the process of obtaining microcapsules, reduction of loss in the process of obtaining microcapsules (increase of the output by weight) are ensured.

EFFECT: claimed method is characterised by application of sodium carboxymethylcellulose as an envelope of microcapsules, fenbendazole as their core, as well as application of two precipitants - butanol and dioxane.

3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry, and represents a method for preparing drug microcapsules by non-solvent addition differing by the fact that the drug preparations are presented by the cephalosporin preparations, while a coating is konjak gum that is precipitated in tetrahydrofurane by the addition of non-solvents that are carbinol and water at 25°C.

EFFECT: invention provides simplified and accelerated preparation of the water-soluble drug microcapsules of cephalosporins in konjac gum, loss reduction in preparing the microcapsules (higher yield-mass).

4 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to chemical-pharmaceutical industry, and represents a method for preparing medicine microcapsules by non-solvent addition differing by the fact that the medical preparations are presented by the cephalosporin preparations, while a coating is polyvinyl alcohol that is precipitated by the addition of non-solvents that are carbinol and acetone at -25°C.

EFFECT: invention provides simplifying and accelerating the process for preparing the water-soluble cephalosporin microcapsules in polyvinyl alcohol, providing loss reduction in preparing the microcapsules (higher yield-mass).

16 ex

FIELD: medicine.

SUBSTANCE: invention relates to food, pharmaceutical and cosmetic industry, in particular deals with oil-in-water emulsion, containing disperse oil drops which have nano-size self-arranging structured internal contents, including: (i) oil, (ii) lipophilic additive (LPA), (iii) hydrophilic domains in form of drops or small canals, containing water or non-water polar liquid, and continuous water phase, which contains emulsion stabilisers or emulsifiers, in which oil drops with diametre from 5 nm to 900 mcm possess nano-size self-arranging structuring with formation of hydrophilic domains with diametre from 0.5 to 200 nm due to presence of lipophilic additive.

EFFECT: invention provides structures able to solubilise not only lipophilic but at the same time hydrophilic and/or amphiphilic, or hydrotropic, or crystalline components.

8 cl, 16 ex, 18 dwg

FIELD: industrial biotechnology; methods of production of the microcapsules.

SUBSTANCE: the invention is pertaining to the industrial biotechnology and is intended for production of the micro-capsulated biopreparations of the natural compounds. The purpose of the invention is development of the effective method of production of the microcapsules of the liquid-phase natural substances. The method is exercised by the emulsification of the encapsulated substance in the polymer solution and sedimentation of the polymer on the surface of the emulsion drips. The sedimentation(is conducted three times at the temperature of 75-80°C during 5-10 minutes at the continuous stirring with the subsequent treatment with the acetone In the capacity of the polymer solution use 1-2.5 % solution of methyl cellulose with the content of the metoxyl groups from 27.5 up to 32 %. In the capacity of the emulsifier use the rape oil in amount of 7.5-40 mass % from the amount of the polymer solution.

EFFECT: the invention ensures development of the effective method of production of the microcapsules of the liquid-phase natural substances.

4 cl, 4 ex

FIELD: colloid chemistry.

SUBSTANCE: method comprises dispersing water emulsion of hydrophobic polymer in a liquid immiscible with water containing emulsifier, producing the emulsion with enriched phase that comprises water dispersed phase containing the hydrophobic polymer, and inducing inter-phase reaction of polycondensation at least of one of the reagents of the inter-phase polycondensation to produce polymeric film around the hydrophobic polymer.

EFFECT: enhanced efficiency.

40 cl, 5 ex

The invention relates to a method of encapsulation of pesticide

The invention relates to microparticles having improved stability during storage, and to a process for the preparation of such microparticles

FIELD: medicine.

SUBSTANCE: what is described is hydrogel composition containing sodium acrylate, a linking agent, biologically active substances, polyvinyl pyrrolidone, glycerol, propanediol, water, a catalyst agent and a radical polymerisation indicator in the following proportions, wt %: sodium acrylate 2.0-10.0, catalyst agent 0.045-0.48, linking agent 0.195-0.21, radical polymerisation indicator 0.045-0.06, glycerol 4.5-7.5, propanediol 3.0-10.5, biologically active substances 0-1.5, polyvinyl pyrrolidone 0.3-1.5, water - the rest. What is described is a surgical dressing containing a carrier with the hydrogel composition applied thereon.

EFFECT: higher efficacy of the hydrogel composition and surgical dressing thereof, lower labour intensity of the method for preparing the above composition.

10 cl, 1 tbl, 2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to pharmaceutical industry, in particular to method of obtaining microcapsules of medications of cephalosporin group. Method of obtaining microcapsules of medications of cephalosporin group consists in the following: surface-active substance is added to konjac solution in toluene, after that, powder of preparation of cephalosporin group is dissolved in dimethylformamide and transferred into solution of konjac in toluene, after formation by antibiotic of its own solid phase carbinol and distilled water are added in drops, obtained suspension of microcapsules is filtered, washed with acetone and dried, with process of obtaining microcapsules being carried out under specified conditions.

EFFECT: method ensures simplification and acceleration of the process of obtaining microcapsules of water-soluble medications.

8 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to the chemical-pharmaceutical industry, and represents a method for preparing drug microcapsules by non-solvent addition differing by the fact that the drug preparations are presented by cephalosporin preparations, while a coating is a konjak gum that is precipitated in acetone by addition of non-solvents that are carbinol and water at 25°C.

EFFECT: invention provides simplified and accelerated preparation of the water-soluble drug microcapsules of cephalosporins in the konjac gum, loss reduction in preparing the microcapsules (higher yield-mass).

6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the field of pharmaceutics, in particular to microcapsulation of medications of a cephalosporin group, belonging to β-lactam antibiotics, in human serum albumin.

EFFECT: realisation of invention results in simplification and acceleration of the process of obtaining microcapsules of water-soluble medications of the cephalosporin group in human serum albumin, reduction of loss in the process of obtaining microcapsules (increase of the output by weight).

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the field of pharmaceutics, in particular, to obtaining fenbendazole capsules. In realisation of a method simplification and acceleration of the process of obtaining microcapsules, reduction of loss in the process of obtaining microcapsules (increase of the output by weight) are ensured.

EFFECT: claimed method is characterised by application of sodium carboxymethylcellulose as an envelope of microcapsules, fenbendazole as their core, as well as application of two precipitants - butanol and dioxane.

3 ex

FIELD: chemistry.

SUBSTANCE: invention relates to a method of modifying envelopes of polyelectrolyte capsules with magnetite nanoparticles. The disclosed method involves producing a container matrix in form of porous calcium carbonate microparticles, forming envelopes of polyelectrolyte capsules by successive adsorption of polyallyl amine and polystyrene sulphonate and modifying with magnetite nanoparticles on the surface of the container matrix or after dissolving the matrix through synthesis of magnetite nanoparticles via chemical condensation.

EFFECT: invention enables to obtain modified polyelectrolyte capsules, designed to deliver medicinal substances which do not harm the human body.

3 cl, 4 dwg, 1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to microcapsulation of cephalosporins related to β-lactam antibiotics. The method is characterised by the fact that konjac gum is used as a microcapsule membrane; a konjak solution cerocon in butyl alcohol is added with the preparation E472 as a surfactant; a powdered antibiotic of cephalosporin is dissolved in water and transferred into the konjak solution cerocon in butyl alcohol; after the antibiotic forms an independent solid phase, carbinol and distilled water are added slowly drop-by-drop; the prepared microcapsule suspension is filtered in acetone and dried; the microcapsule process is performed at 25°C with no special equipment required; the relation of carbinol and butyl alcohol makes 1:3.

EFFECT: invention provides simplified and accelerated preparation of the water-soluble drug microcapsules of cephalosporins in konjac gum, loss reduction in preparing the microcapsules (higher yield-mass).

6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to method of obtaining microcapsules of medication of cephalosporin group in konjac gum. In accordance with claimed method cephalosporin powder, preliminarily dissolved in dimethylformamide, and surface-active substance are added to konjac gum solution in isopropyl alcohol, with addition of carbinol after formation of independent solid phase by cephalosporin. Obtained suspension of microcapsules is filtered, washed with acetone and dried in dessicator.

EFFECT: invention makes it possible to simplify and accelerate process of obtaining microcapsules of water-soluble medications of cephalosporin groups in konjac gum, as well as to increase their output by weight.

4 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to method of obtaining microcapsules of medication of cephalosporin group in poludanum. In accordance with claimed method cephalosporin powder and surface-active substance are added to aqueous solution of poludanum, mixture is mixed until components dissolve completely, after formation of transparent solution carbinol and after it isopropyl alcohol are additionally poured in. Obtained suspension of microcapsules is filtered, washed with acetone and dried in dessicator.

EFFECT: invention makes it possible to simplify and accelerate process of obtaining microcapsules of water-soluble medications of cephalosporin groups in poludanum, as well as to increase their output by weight.

4 ex

FIELD: veterinary medicine.

SUBSTANCE: method comprises the use of encapsulated fenbendazol. Sodium carboxymethyl cellulose is used as coating of the microcapsules. The microcapsules are obtained by the physico-chemical method of nonsolvent addition using two precipitators - carbinol and cyclohexanol. The ratio of core/polymer is 1:3. The preparation is given to animals at a dose of 22.5 mg/kg (15 mg/kg as active agent) as a single dose.

EFFECT: method is simple to use and is highly effective in the treatment of cattle with strongylatosis.

1 tbl

FIELD: medicine.

SUBSTANCE: improving the psychomotor action in individuals suffering from mild and moderate anxiodepressive disorders is ensured by prescribing anxiolytic afobazol in a daily dose of 30-60 mg divided in three times throughout the day. The therapeutic course makes 14 days.

EFFECT: invention provides higher speed of hand-eye reactions accompanied by reduced responsiveness to a visual signal.

1 tbl

Up!